Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LEAP Technologies is a leading provider of laboratory automation solutions specializing in sample preparation and analytical instrumentation for the life sciences and pharmaceutical industries. The company is widely recognized for its expertise in Hydrogen-Deuterium Exchange (HDX) automation, which is critical for studying protein dynamics and biotherapeutic characterization. LEAP offers customized robotic platforms, such as the PAL system, integrated with Liquid Chromatography-Mass Spectrometry (LC/MS) workflows to enhance laboratory efficiency and data reproducibility. Their solutions are utilized by major pharmaceutical companies and academic research centers globally to accelerate drug discovery and structural biology research. Since its acquisition by Trajan Scientific and Medical in 2016, LEAP has continued to support global research organizations with advanced fluidic and robotic technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LEAP Technologies.